SmartLinx Vitals Plus Patient Monitoring System
by Capsule Technologie 2 variants
510(k) K183638
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK183638 | Date17 Apr 2019 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- MWI
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.2300
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The SmartLinx Vitals Plus Patient Monitoring System is a medical device classified as a Patient Monitoring System (Product Code MWI) designed to continuously monitor and alarm physiologic parameters. It measures non-invasive blood pressure (systolic, diastolic, and mean arterial pressure), pulse rate, functional arterial oxygen saturation (SpO₂), and temperature across adult, pediatric, and neonatal patients.
This system is intended for use in non-critical care hospital settings, providing integrated surveillance of vital signs. Supplied as a reusable device, it requires adherence to standard infection control protocols. Authorized under FDA 510(k) clearance (K183638), it was determined substantially equivalent through the Cardiovascular (CV) advisory committee review.